Gastrointestinal side effects The most frequently reported side effects associated with retatrutide treatment are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation
References Porsbjerg C, Melen E, Lehtimaki L, Shaw D, Asthma (2023) Lancet 401(10379):858873 Diseases GBD, Injuries C (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 19902019: a systematic analysis for the global burden of disease study 2019
Is 5-Amino-1MQ legal in Australia
Administration: A qualified professional administers the injection directly into the muscle
Klemens, 1993
Lancet 378:584594 Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL (2000) Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism